PRGO
37
2
NRG
62
-13
WDC
63
2
COP
36
5
GD
49
4
MKC
63
6
ROST
49
2
GOOGL
56
2
CAT
48
2
OMC
33
4
HD
43
-3
CCL
70
2
UAL
51
4
D
43
-2
CMS
55
2
JBHT
40
14
MPC
42
6
VNO
59
2
O
46
2
DE
60
12
PRGO
37
2
NRG
62
-13
WDC
63
2
COP
36
5
GD
49
4
MKC
63
6
ROST
49
2
GOOGL
56
2
CAT
48
2
OMC
33
4
HD
43
-3
CCL
70
2
UAL
51
4
D
43
-2
CMS
55
2
JBHT
40
14
MPC
42
6
VNO
59
2
O
46
2
DE
60
12
Financhill
Back

Nuveen AMT-Free Municipal Income Fund Vs. Akero Therapeutics Industry Stock Comparison

Sell
27

NEA
Nuveen AMT-Free Municipal Income Fund

Last Price:
$10.81
Seasonality Move:
0.06%
Buy
68

AKRO
Akero Therapeutics

Last Price:
$54.34
Seasonality Move:
26.74%
Sell
27
Nuveen AMT-Free Municipal Income Fund (NEA) is a Sell

Is Nuveen AMT-Free Municipal Income Fund a Buy, Sell or Hold?

  • The current Nuveen AMT-Free Municipal Income Fund [NEA] share price is $10.81. The Score for NEA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NEA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $54.28. The Score for AKRO is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NEA Stock Price Chart

What is Nuveen AMT-Free Municipal Income Fund's stock price today?

  • The Nuveen AMT-Free Municipal Income Fund share price today is $10.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEA is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $54.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

NEA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 46.19 Sell
Chaikin Money Flow: -286598 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.81 - 10.97) Sell
Bollinger Bands (100): (10.81 - 11.45) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.09 Buy
Relative Strength Index (14 RSI): 70.44 Buy
Chaikin Money Flow: -1219058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.53 - 50.43) Buy
Bollinger Bands (100): (34.89 - 51.35) Buy

NEA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.82 Sell
20-day SMA: 10.86 Sell
50-day SMA: 10.86 Sell
200-day SMA: 11.39 Sell
8-day EMA: 10.82 Sell
20-day EMA: 10.84 Sell
50-day EMA: 10.92 Sell
200-day EMA: 11.19 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.82 Buy
20-day SMA: 46 Buy
50-day SMA: 42.47 Buy
200-day SMA: 36.08 Buy
8-day EMA: 51.3 Buy
20-day EMA: 47.76 Buy
50-day EMA: 44.57 Buy
200-day EMA: 37.75 Buy

Nuveen AMT-Free Municipal Income Fund Earnings Growth & NEA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Nuveen AMT-Free Municipal Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):